These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15177146)

  • 1. Circulating levels of the neuropeptide hormone somatostatin may determine hepatic fibrosis in Schistosoma mansoni infections.
    Chatterjee S; Mbaye A; Alfidja AT; Weyler J; Scott JT; Van Damme P; Van De Vijver K; Deelder A; Van Marck EA
    Acta Trop; 2004 Apr; 90(2):191-203. PubMed ID: 15177146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower levels of the circulating neuropeptide somatostatin in Schistosoma mansoni infected patients may have pathological significance.
    Chatterjee S; Mbaye A; Van Marck E
    Trop Med Int Health; 2003 Jan; 8(1):33-6. PubMed ID: 12535248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.
    Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E
    BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of ultrasonographic evidence for severe hepatosplenic morbidity in schistosomiasis mansoni in Mali.
    Kardorff R; Traore M; Diarra A; Sacko M; Maiga M; Franke D; Vester U; Hansen U; Traore HA; Fongoro S
    Am J Trop Med Hyg; 1994 Aug; 51(2):190-7. PubMed ID: 8074253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity.
    Doehring-Schwerdtfeger E; Abdel-Rahim IM; Mohamed-Ali Q; Elsheikh M; Schlake J; Kardorff R; Franke D; Kaiser C; Ehrich JH
    Am J Trop Med Hyg; 1990 Jun; 42(6):581-6. PubMed ID: 2115307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity of Schistosoma mansoni, hepatitis B, age, and sex predict levels of hepatic periportal thickening/fibrosis (PPT/F): a large-scale community-based study in Ethiopia.
    Berhe N; Myrvang B; Gundersen SG
    Am J Trop Med Hyg; 2007 Dec; 77(6):1079-86. PubMed ID: 18165526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection.
    de Jesus AR; Magalhães A; Miranda DG; Miranda RG; Araújo MI; de Jesus AA; Silva A; Santana LB; Pearce E; Carvalho EM
    Infect Immun; 2004 Jun; 72(6):3391-7. PubMed ID: 15155645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adhesion molecules in patients with different clinical forms of S. mansoni infection.
    Talaat RM; El-Bassiouny A; Osman A; Yossif M; Charmy R; Al-Sherbiny M
    Egypt J Immunol; 2005; 12(2):143-54. PubMed ID: 17977219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity of schistosomiasis mansoni in rural Alexandria, Egypt.
    Zaki A; Bassili A; Amin G; Aref T; Kandil M; Abou Basha LM
    J Egypt Soc Parasitol; 2003 Dec; 33(3):695-710. PubMed ID: 14708847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound versus clinical examination as indication for Schistosoma mansoni associated morbidity in children.
    Doehring-Schwerdtfeger E; Kaiser C; Schlake J; Abdel-Rahim IM; Mohamed-Ali Q; Richter J; Franke D; Kardorff R; Elsheikh M; Ehrich JH
    Trop Med Parasitol; 1992 Dec; 43(4):245-8. PubMed ID: 1293729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis.
    Cai P; Mu Y; Olveda RM; Ross AG; Olveda DU; McManus DP
    EBioMedicine; 2018 Nov; 37():334-343. PubMed ID: 30482723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatosplenic alterations determined by ultrasonography in a population recently infected with Schistosoma mansoni in Richard-Toll, Senegal.
    Rouquet P; Verlé P; Kongs A; Talla I; Niang M
    Trans R Soc Trop Med Hyg; 1993; 87(2):190-3. PubMed ID: 8337726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultrasonographic study of liver fibrosis in patients infected with Schistosoma mansoni in north-east Brazil.
    Domingues AL; Lima AR; Dias HS; Leao GC; Coutinho A
    Trans R Soc Trop Med Hyg; 1993; 87(5):555-8. PubMed ID: 8266409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Periportal fibrosis in Schistosoma mansoni schistosomiasis. An ultrasonographic study in the area of Nkolbisson (Cameroon)].
    Nko'O-Amvene S; Biwole Sida M; Kouemeni L; Ndjma Maga GR; Same Ekobo A; Mbo Amvene J; Edzoa T
    J Radiol; 1993 May; 74(5):269-74. PubMed ID: 8320660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of laminin and beta-subunit of prolyl 4-hydroxylase in the sera of human subjects with Schistosomiasis mansoni.
    Tanabe M; Sekiguchi T; Kaneko N; Kobayashi S; Takeuchi T; Coutinho A; Tateno S; Maruyama K; Okazaki I
    Jpn J Exp Med; 1989 Jun; 59(3):109-19. PubMed ID: 2554032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni.
    Homeida MA; el Tom I; Nash T; Bennett JL
    Am J Trop Med Hyg; 1991 Sep; 45(3):360-5. PubMed ID: 1928571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of somatostatin in schistosomiasis: a basis for immunomodulation in host-parasite interactions?
    Chatterjee S; Van Marck E
    Trop Med Int Health; 2001 Aug; 6(8):578-81. PubMed ID: 11555424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of echography in the study of periportal fibrosis caused by schistosomiasis in an endemic African zone].
    Lamothe F; Develoux M; N'Goran E; Yapi Y; Sellin B
    Ann Radiol (Paris); 1990; 33(1):44-7. PubMed ID: 2163231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
    Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
    J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.